PerkinElmer Inc at Barclays Global Healthcare Conference (Virtual) Transcript
All right. I think we're ready to go. Good morning, everybody, Luke Sergott from Barclays. I cover life science tools and diagnostics here. It is my great pleasure to introduce Prahlad Singh from PerkinElmer. He had taken over during an easy time to take over a company right ahead of a pandemic. So with that, if you want to provide some -- a quick couple sentences background and overview, and then we can just dive right into questions, if that works for you.
Sounds good. Good morning. Thank you, Luke, for the opportunity. It's been an interesting 14 months now. When we began the year, obviously, our focus was we have put a lot of effort in reorganizing the company, combining our commercial teams, uniting -- unifying R&D and bringing it together, both the erstwhile DAS and DX segments from a commercial and a technology perspective. And going into 2020, we were very excited about the progress we would make. But
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
